RecruitingNot Applicable

Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis

Italy40 participantsStarted 2021-04-08

Plain-language summary

In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a certain diagnosis of cystic fibrosis and visited during normal clinical practice, in accordance with the standard operating procedures in force at the Centres. * Both sexes * Age \>18 years * Obtaining informed consent for patients (based on the procedures established by the protocol). Exclusion Criteria: * Patients unable to understand the instructions and information provided and be able to adequately accept the study methods.

What they're measuring

profile of specific cell populations and expression markers to determine the development and progression of M. abscessus lung disease in patients with CF

Timeframe: One month after enrollment visit

Trial details

NCT IDNCT06413459

SponsorOspedale San Raffaele

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-03-30

Contact for this trial

Nicola I Lorè, PhD

+390226434902 lore.nicolaivan@hsr.it

View on ClinicalTrials.gov More Non-Tuberculous Mycobacterial Pneumonia trials